Algerian Chamomile Shows Promising Therapeutic Properties in Recent Study

A recent scientific investigation has identified that a type of chamomile growing in a desert region of Algeria possesses substances exhibiting anti-inflammatory, antibacterial, antidiabetic, and nerve-supportive properties.

Researchers discovered that the extract from this chamomile variety contains elevated levels of polyphenols and flavonoids, along with several biologically active compounds such as caffeic acid and apigenin-7-O-glucoside, both known for their antioxidant and anti-inflammatory effects.

Laboratory tests demonstrated that the extract inhibited the growth of Staphylococcus aureus bacteria and Candida albicans fungi. Additionally, it reduced the activity of the alpha-amylase enzyme, which is involved in carbohydrate breakdown and may play a role in blood sugar regulation. The chamomile also showed the ability to inhibit enzymes linked to cognitive decline in neurodegenerative diseases.

The anti-inflammatory effect of the extract was confirmed in animal experiments, where it decreased swelling in mice with induced inflammation.

Researchers emphasize that these findings derive from preclinical studies, and chamomile should not yet be considered a ready treatment. However, the current data suggest that chamomile could serve as a source for compounds to develop new therapeutic agents.

Health experts note that chamomile contributes to overall health by improving digestive system function and alleviating anxiety that affects the intestines and stomach. Some nutrition specialists also affirm that chamomile assists in lowering blood sugar levels.